Antibody production by spleen cells of mice bearing MCA-induced tumours: search for suppressor cells. 1978

M Yagello, and G Lespinats, and W H Fridman

The antibody response to sheep red blood cells of spleen cells from mice bearing a methylcholanthrene (MCA)-induced tumour was measured with the local hemolysis technique, after in vivo or in vitro immunization. The in vivo data varied according to the stage of tumour growth and were related to the splenomegaly developing during the tumour growth process. During the first 10--15 days after tumour grafting, the total number of plaque-forming cells in the spleen increase in proportion to the spleen growth and thereafter remained relatively constant although the splenomegaly still progressed. Experiments performed in vitro were used to test the antibody response of mixtures of cells from normal mice and syngeneic tumour-bearing animals. In most cases, no suppression of antibody production, due to cells from tumour-bearing hosts, could be detected. The results suggest that those cells, which suppress cell-mediated immune reactions, previously found in the spleen of animals bearing the MCA-induced tumour, do not suppress antibody production.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D008809 Mice, Inbred C3H An inbred strain of mouse that is used as a general purpose strain in a wide variety of RESEARCH areas including CANCER; INFECTIOUS DISEASES; sensorineural, and cardiovascular biology research. Mice, C3H,Mouse, C3H,Mouse, Inbred C3H,C3H Mice,C3H Mice, Inbred,C3H Mouse,C3H Mouse, Inbred,Inbred C3H Mice,Inbred C3H Mouse
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D006462 Hemolytic Plaque Technique A method to identify and enumerate cells that are synthesizing ANTIBODIES against ANTIGENS or HAPTENS conjugated to sheep RED BLOOD CELLS. The sheep red blood cells surrounding cells secreting antibody are lysed by added COMPLEMENT producing a clear zone of HEMOLYSIS. (From Illustrated Dictionary of Immunology, 3rd ed) Jerne's Plaque Technique,Hemolytic Plaque Technic,Jerne's Plaque Technic,Hemolytic Plaque Technics,Hemolytic Plaque Techniques,Jerne Plaque Technic,Jerne Plaque Technique,Jernes Plaque Technic,Jernes Plaque Technique,Plaque Technic, Hemolytic,Plaque Technic, Jerne's,Plaque Technics, Hemolytic,Plaque Technique, Hemolytic,Plaque Technique, Jerne's,Plaque Techniques, Hemolytic,Technic, Hemolytic Plaque,Technic, Jerne's Plaque,Technics, Hemolytic Plaque,Technique, Hemolytic Plaque,Technique, Jerne's Plaque,Techniques, Hemolytic Plaque
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000912 Antibodies, Neoplasm Immunoglobulins induced by antigens specific for tumors other than the normally occurring HISTOCOMPATIBILITY ANTIGENS. Neoplasm Antibodies,Tumor Antibodies,Antibodies, Tumor
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen
D012513 Sarcoma, Experimental Experimentally induced neoplasms of CONNECTIVE TISSUE in animals to provide a model for studying human SARCOMA. EHS Tumor,Sarcoma, Engelbreth-Holm-Swarm,Sarcoma, Jensen,Experimental Sarcoma,Experimental Sarcomas,Sarcomas, Experimental,Engelbreth-Holm-Swarm Sarcoma,Jensen Sarcoma,Sarcoma, Engelbreth Holm Swarm,Tumor, EHS
D013154 Spleen An encapsulated lymphatic organ through which venous blood filters.

Related Publications

M Yagello, and G Lespinats, and W H Fridman
October 1980, Cancer research,
M Yagello, and G Lespinats, and W H Fridman
August 1965, Science (New York, N.Y.),
M Yagello, and G Lespinats, and W H Fridman
January 1980, Microbiology and immunology,
M Yagello, and G Lespinats, and W H Fridman
May 1964, Science (New York, N.Y.),
M Yagello, and G Lespinats, and W H Fridman
January 1986, International journal of immunopharmacology,
M Yagello, and G Lespinats, and W H Fridman
January 1975, Transplantation reviews,
M Yagello, and G Lespinats, and W H Fridman
November 1982, Comptes rendus des seances de l'Academie des sciences. Serie III, Sciences de la vie,
M Yagello, and G Lespinats, and W H Fridman
April 1988, Japanese journal of medical science & biology,
Copied contents to your clipboard!